Showing results (1841-1850 of 2,232) with videos related to
Sort By:
Pageof 224
The Biochemical Journal|March 15, 1986
The cloning and sequence analysis of the aspC and tyrB genes from Escherichia coli K12. Comparison of the primary structures of the aspartate aminotransferase and aromatic aminotransferase of E. coli with those of the pig aspartate aminotransferase isoenzymesI G Fotheringham, S A Dacey, P P Taylor, et al.The Journal of Pharmacology and Experimental Therapeutics|January 14, 2005
Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeysJeannie R Rojas, Ronald P Taylor, Mark R Cunningham, et al.Journal of Medicinal Chemistry|March 1, 1988
Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivativesJ S New, J P Yevich, D L Temple, et al.Annals of Neurology|May 31, 2023
Expert Panel Curation of 113 Primary Mitochondrial Disease Genes for the Leigh Syndrome SpectrumElizabeth M McCormick, Kierstin Keller, Julie P Taylor, et al.Ejhaem|July 18, 2022
Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case seriesLeila Motedayen Aval, Mary Boullier, Hermione Lyall, et al.Nucleic Acids Research|January 10, 2003
PRINTS and its automatic supplement, prePRINTST K Attwood, P Bradley, D R Flower, et al.Journal of Clinical Microbiology|August 1, 2002
Transmission of drug-resistant tuberculosis in Texas and MexicoTeresa N Quitugua, Barbara J Seaworth, Stephen E Weis, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemiaAdam D Kennedy, Paul V Beum, Michael D Solga, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemiaMichael E Williams, John J Densmore, Andrew W Pawluczkowycz, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2014
Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemiaNisar A Baig, Ronald P Taylor, Margaret A Lindorfer, et al.Pageof 224